Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Rettig

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
Molecular Therapy. Methods & Clinical Development|June 2, 2020
Increasing CRISPR Efficiency and Measuring Its Specificity in HSPCs Using a Clinically Relevant SystemJenny Shapiro, Ortal Iancu, Ashley M Jacobi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 16, 2023
Comparative analysis of CRISPR off-target discovery tools following ex vivo editing of CD34<sup>+</sup> hematopoietic stem and progenitor cellsM Kyle Cromer, Kiran R Majeti, Garrett R Rettig, et al.
Nature Communications|May 25, 2021
CRISPECTOR provides accurate estimation of genome editing translocation and off-target activity from comparative NGS dataIdo Amit, Ortal Iancu, Alona Levy-Jurgenson, et al.
Molecular Therapy. Methods & Clinical Development|May 13, 2021
CRISPAltRations: a validated cloud-based approach for interrogation of double-strand break repair mediated by CRISPR genome editingGavin Kurgan, Rolf Turk, Heng Li, et al.
Methods (San Diego, Calif.)|March 30, 2017
Simplified CRISPR tools for efficient genome editing and streamlined protocols for their delivery into mammalian cells and mouse zygotesAshley M Jacobi, Garrett R Rettig, Rolf Turk, et al.
European Journal of Endocrinology|April 13, 2012
Screening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studiesA Hannemann, M Bidlingmaier, N Friedrich, et al.
Blood|December 31, 1997
Localization of Kaposi's sarcoma-associated herpesvirus in bone marrow biopsy samples from patients with multiple myelomaJ W Said, M R Rettig, K Heppner, et al.
The Journal of Infection|July 3, 2024
Real-world experience with letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation: A multi-centre observational studySina M Hopff, Sebastian M Wingen-Heimann, Annika Y Classen, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 15, 2026
Healthcare resource utilization and costs of letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation in a real-world, multi-centre study in GermanyMarie Engelhard, Sebastian M Wingen-Heimann, Annika Y Classen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 4, 2013
Knockdown of β-catenin with dicer-substrate siRNAs reduces liver tumor burden in vivoHenryk Dudek, Darren H Wong, Rokhand Arvan, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
Molecular Therapy. Methods & Clinical Development|June 2, 2020
Increasing CRISPR Efficiency and Measuring Its Specificity in HSPCs Using a Clinically Relevant SystemJenny Shapiro, Ortal Iancu, Ashley M Jacobi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 16, 2023
Comparative analysis of CRISPR off-target discovery tools following ex vivo editing of CD34<sup>+</sup> hematopoietic stem and progenitor cellsM Kyle Cromer, Kiran R Majeti, Garrett R Rettig, et al.
Nature Communications|May 25, 2021
CRISPECTOR provides accurate estimation of genome editing translocation and off-target activity from comparative NGS dataIdo Amit, Ortal Iancu, Alona Levy-Jurgenson, et al.
Molecular Therapy. Methods & Clinical Development|May 13, 2021
CRISPAltRations: a validated cloud-based approach for interrogation of double-strand break repair mediated by CRISPR genome editingGavin Kurgan, Rolf Turk, Heng Li, et al.
Methods (San Diego, Calif.)|March 30, 2017
Simplified CRISPR tools for efficient genome editing and streamlined protocols for their delivery into mammalian cells and mouse zygotesAshley M Jacobi, Garrett R Rettig, Rolf Turk, et al.
European Journal of Endocrinology|April 13, 2012
Screening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studiesA Hannemann, M Bidlingmaier, N Friedrich, et al.
Blood|December 31, 1997
Localization of Kaposi's sarcoma-associated herpesvirus in bone marrow biopsy samples from patients with multiple myelomaJ W Said, M R Rettig, K Heppner, et al.
The Journal of Infection|July 3, 2024
Real-world experience with letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation: A multi-centre observational studySina M Hopff, Sebastian M Wingen-Heimann, Annika Y Classen, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 15, 2026
Healthcare resource utilization and costs of letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation in a real-world, multi-centre study in GermanyMarie Engelhard, Sebastian M Wingen-Heimann, Annika Y Classen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 4, 2013
Knockdown of β-catenin with dicer-substrate siRNAs reduces liver tumor burden in vivoHenryk Dudek, Darren H Wong, Rokhand Arvan, et al.
Pageof 11